SPC
MDT icon

Spirepoint Private Client’s Medtronic MDT Stock Holding History

Spirepoint Private Client’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,060
Closed -$352K – 341
2026
Q1 		$352K Sell
4,060
-688
-14% -$65.9K 0.03% 233
2025
Q4 		$456K Buy
4,748
+693
+17% +$67.3K 0.04% 184
2025
Q3 		$386K Buy
4,055
+156
+4% +$14.3K 0.04% 190
2025
Q2 		$340K Hold
3,899
– – 0.04% 183
2025
Q1 		$350K Sell
3,899
-2,525
-39% -$226K 0.05% 164
2024
Q4 		$513K Sell
6,424
-34,733
-84% -$3.01M 0.06% 143
2024
Q3 		$3.71M Buy
41,157
+5,344
+15% +$450K 0.49% 51
2024
Q2 		$2.82M Buy
35,813
+4,609
+15% +$378K 0.4% 55
2024
Q1 		$2.72M Buy
+31,204
New +$2.66M 0.41% 52

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Spirepoint Private Client's MDT Position: Q2 2026 in Review

Spirepoint Private Client sold out of Medtronic (MDT) in Q2 2026, closing a stake of 4,060 shares — an estimated $352K sold.

Spirepoint Private Client first reported a position in MDT in Q1 2024 and held it in 9 quarters. The position peaked at $3.71M in Q3 2024. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Spirepoint Private Client reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Spirepoint Private Client sold 4,060 Medtronic shares in Q2 2026, an estimated $352K.
  • Spirepoint Private Client first reported a position in Medtronic in Q1 2024 and held it in 9 quarters.
  • Spirepoint Private Client's Medtronic position peaked at $3.71M in Q3 2024.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Spirepoint Private Client's 13F filing for Q2 2026, filed 5 Aug 2026.